novocure(NVCR) - 2024 Q4 - Annual Results

EXHIBIT 99.1 Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update Preliminary full year 2024 net revenues of $605 million and fourth quarter net revenues of$161 million Novocure to present at the 43 Annual J.P. Morgan Healthcare Conference at 9:00 a.m. PST on Wednesday, January 15, 2025 rd BAAR, Switzerland – Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2024 ...